1. Home
  2. BMHL vs BNR Comparison

BMHL vs BNR Comparison

Compare BMHL & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluemount Holdings Limited Class B Ordinary Shares

BMHL

Bluemount Holdings Limited Class B Ordinary Shares

HOLD

Current Price

$3.50

Market Cap

152.9M

Sector

N/A

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

SELL

Current Price

$15.01

Market Cap

169.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BMHL
BNR
Founded
2016
2014
Country
Hong Kong
China
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.9M
169.9M
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
BMHL
BNR
Price
$3.50
$15.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.3K
★ 36.7K
Earning Date
03-30-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$101.46
Revenue Next Year
N/A
$14.81
P/E Ratio
$66.66
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.72
$6.79
52 Week High
$6.35
$41.72

Technical Indicators

Market Signals
Indicator
BMHL
BNR
Relative Strength Index (RSI) 26.62 51.96
Support Level $3.20 $8.91
Resistance Level $3.88 $19.10
Average True Range (ATR) 0.52 1.46
MACD -0.13 -0.42
Stochastic Oscillator 8.55 11.56

Price Performance

Historical Comparison
BMHL
BNR

About BMHL Bluemount Holdings Limited Class B Ordinary Shares

Bluemount Holdings Ltd through its operating subsidiaries, is a Hong Kong-based consulting and advisory, financial services, and luxury timepiece trading provider. The Company provides consulting and advisory services on business development strategies, including seeking suitable transaction projects for business development or diversification and suitable business partners or investors for fund-raising projects. Its services are centered around three core offerings: Business Transformation, Strategy, and Transactions. The Company also sources, buys, and sells brand-new luxury branded timepieces. It operates through two reportable segments: security-related services and asset management, and trading of timepieces, with the trading of timepieces generating maximum revenue.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Share on Social Networks: